Kathryn Martin
Advertisement
Articles by Kathryn Martin
Advertisement
Latest Updated Articles
24 Real-world Use of Neratinib Post-Pertuzumab (P) and –Ado-Trastuzumab Emtansine (T-DM1)Published: April 18th 2022 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
How Will the Continued Success of ADCs in Breast Cancer Be Propelled in the Future?
2
Neoadjuvant Nivolumab/Ipilimumab Shows Superior EFS in Resectable Melanoma
3
Trial Assessing Savolitinib/Osimertinib in NSCLC Completes Enrollment
4
Managing Early Adverse Events With Amivantamab + Lazertinib
5
